OR WAIT null SECS
December 23, 2020
The virtual manufacturer and distributor of specialty materials acquired the NY-based company, adding analytical and manufacturing expertise.
The UK company is investing £3 million in new instrumentation and equipment to strengthen its high-throughput screening and translational oncology service offerings.
December 16, 2020
A newly developed polymer, DynaShield, may have the capability to ensure global access for COVID-19 treatment and prevention.
The product represents a first-of-its-kind intentional genomic alteration in a line of domestic pigs that may be used for human therapeutics.
The films are now available in three options of varying thickness for added protection against moisture and oxygen.
The company has formed an agreement with the Ministry of Health of Singapore to supply mRNA-1273, Moderna’s COVID-19 vaccine candidate, to the people of Singapore.
John Rim, the company’s former executive vice-president, has been named its new president and CEO.
December 15, 2020
The companies are entering into a license and collaboration agreement for the development and commercialization of Relay’s investigational cancer treatment, RLY-1971, a potent inhibitor of SHP2, a molecule that plays a role in cancer cell survival.
The company will expand its clinical supply chain services by establishing two new facilities in Rheinfelden and Weil am Rhein, Germany.
Freezers, shipping containers, and tracking systems aid distribution of COVID-19 vaccines.